This article is more than 5 years old. Information may no longer be current.
Speaker: Omidria use decreases need for Malyugin ring in cataract surgery
Click Here to Manage Email Alerts
NEW ORLEANS – Malyugin ring use decreased by about two-thirds in one surgeon’s experience when he used Omidria to maintain pupil width in patients undergoing routine cataract surgery.
“The stuff works,” Luther L. Fry, MD, said in a presentation at the American Society for Cataract and Refractive Surgery meeting. Fry described himself as a “skeptic” who wanted to test Omidria (1% phenylephrine and 0.3% ketorolac injection, Omeros) for himself.
Pupil size at mid-case and at the end of the case was significantly larger when Omidria was used, Fry said.
The randomized study included 60 consecutive routine cataract patients who underwent surgery with or without Omidria preoperatively.
Pupil size was measured at the start of each case and after phaco. Patients also rated their discomfort level on a scale of 1 to 3, with 3 being greater discomfort. Patient discomfort, both during the case and in the first 24 hours, was not significantly different, according to the report. However, the discomfort level was so low that a conclusion could not be reached in the small study, according to Fry.
Results showed that pupil size was significantly larger preoperatively, intraoperatively and postoperatively in the Omidria group than in the control group.
“The main thing is that my Malyugin use has decreased by about two-thirds and I can be confident during the case that the pupil is going to stay up,” Fry said.“– by Kate Sherrer
Reference:
Fry, LL. Effect of phenylephrine – ketorolac in maintaining mydriasis and intraoperative and first 24-hour comfort level during routine cataract surgery. Presented at: American Society of Cataract and Refractive Surgery meeting; May 6-10, 2016. New Orleans.
Disclosure: Fry reports no relevant financial disclosures.